Quest Diagnostics 2002 Annual Report Download - page 13

Download and view the complete annual report

Please find page 13 of the 2002 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 107

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107

QUEST DIAGNOSTICS 11
We are committed to meeting the exacting requirements of specialists
like Dr. Kara Quan. Specialists use highly sensitive tests to diagnose,
treat and monitor their patients, and the results can have life-or-death
implications. Consider the therapeutic drug-monitoring tests that
Dr. Quan uses to evaluate her heart patients. “It is important to know
the reliability of what we’re comparing because there’s a therapeutic
index of what we know is effective in a patient,” she explains. “A little
margin above that could be toxic, and a little below may not provide
effective heart-rhythm control. That’s why we send tests to a quality
reference laboratory, such as Quest Diagnostics.”
Whether their field is cardiology, cancer, women’s health, infectious
disease or endocrinology, specialists rely on Quest Diagnostics for our
quality, expertise, reliability and convenience. Our Quest Diagnostics
Nichols Institute esoteric testing laboratories are world renowned for
quality and for their medical and scientific directors, who are always
available for consultation with clients like Dr. Quan.
Cardiovascular disease is the leading cause of death in the United
States, and we offer a full complement of routine and esoteric heart-risk
tests. Our broad test menu ranges from routine HDL and LDL cholesterol
and triglycerides to complex esoteric tests for cholesterol sub-particle
fractionation and new potential markers for heart attack risk, such as
Cardio CRP and homocysteine. Our alliance with Celera Diagnostics will
provide access to new, potentially significant genetic markers for the risk
of cardiovascular disease as well as diabetes.
In women’s health, we led the adoption of monolayer technology for
cervical cancer screening. We also developed a comprehensive
gene-based test to diagnose and detect carriers of cystic fibrosis, our
new proprietary CF Complete™ test, which sequences the entire CF
gene and identifies more than 1,000 distinct mutations.
Whatever the specialty, more physicians trust us to perform highly
specialized esoteric tests than anyone else.
RICHARD E. REITZ, M.D., Medical Director
Quest Diagnostics Nichols Institute
With more than 300 physicians and scientists, including
Dr. Richard Reitz, our medical and scientific staff provides
diagnostic insights to physicians that help improve patient care.
Quest Diagnostics offers more than 3,000 different routine and specialized tests